Skip to content

Mats B Lindström

2 papers in the library · 113 citations · publishing 2021-2025

Papers

Sort Most recent Most cited

Sleep-administered ketamine/psychedelics: A streamlined strategy to address two challenges in research on ketamine and psychedelics.

European psychiatry : the journal of the Association of European Psychiatrists February 5, 2025 Shokouh Arjmand, Mats B Lindström, Carl M Sellgren et al. 1 citation

The dissociative effects of ketamine and psychedelics might be associated with their rapid antidepressant properties, raising questions about whether these effects are necessary for their therapeutic action. Additionally, the distinct dissociative experiences often reported by patients in clinical trials may reveal whether they receive an active treatment or a placebo, potentially introducing...

Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT)

International Journal of Neuropsychopharmacology December 4, 2021 Joakim Ekstrand, Christian Fattah, Marcus Persson et al. 112 citations

Abstract Background Ketamine has emerged as a fast-acting and powerful antidepressant, but no head to head trial has been performed, Here, ketamine is compared with electroconvulsive therapy (ECT), the most effective therapy for depression. Methods Hospitalized patients with unipolar depression were randomized (1:1) to thrice-weekly racemic ketamine (0.5 mg/kg) infusions or ECT in a parallel,...